Safety profile of drugs for advanced melanoma: A report based on 2008-2018 US Food and Drug Administration Data
- 1 July 2021
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 87 (7) , 2988-2995
Abstract
We describe the safety profiles of all drug classes used for the treatment of advanced melanoma from the US Food and Drug Administration Adverse Event Reporting System over 2008-2018. Adverse reactions reported in 25 900 pharmacovigilance cases are described for chemotherapies, immunomodulators, targeted therapies and immunotherapies. There was a sharp increase in the number of cases over time, with peaks associated with the launch of new treatments. The adverse reactions diversified over time; notably, skin (alopecias, dermatitis) and retinal disorders were frequently associated with targeted therapies and endocrine disorders (hypothalamus, thyroid and adrenal dysfunctions) with immunotherapies. Less well-known reactions were also detected, such as neuropsychiatric disorders with targeted therapies and gastrointestinal ulcers, pneumothorax and pleural effusions with immunotherapies. The findings highlight the need for various health professionals (including medical specialists or trained nurses) to enhance management of complications.Keywords
This publication has 25 references indexed in Scilit:
- Systemic Therapies for Advanced MelanomaDermatologic Clinics, 2019
- Targeted therapy for malignant melanomaCurrent Opinion in Pharmacology, 2019
- Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted AgentsAsia-Pacific Journal of Oncology Nursing, 2018
- Epidemiology of Melanoma2017
- Metastatic melanoma and immunotherapyClinical Immunology, 2016
- Harnessing the immune system to improve cancer therapyAnnals of Translational Medicine, 2016
- Novel antibodies targeting immune regulatory checkpoints for cancer therapyBritish Journal of Clinical Pharmacology, 2013
- Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigmTherapeutic Advances in Medical Oncology, 2012
- Contemporary Surgical Treatment of Advanced-Stage MelanomaArchives of Surgery, 2004
- Malignant melanoma: prevention, early detection, and treatment in the 21st centuryCA: A Cancer Journal for Clinicians, 2000